Published

From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Journal of nervous and mental disease
Date: 2022-08-01
Source: PubMed
DOI: 10.1097/nmd.0000000000001489
PubMed: 35900779

Authors

Suleiman M Basu A Belal S Jacob T

Watch author

Derived topics and classifications

psilocybin End-of-Life Distress Microdosing Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.2022-08-01

Related papers

Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.The primary care companion for CNS disorders · 2024-01-16 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22 An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.Bipolar disorders · 2021-11-01 Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2026-08-05 Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleClinicalTrials.gov · 2026-05-12 Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.Journal of eating disorders · 2025-07-24 Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28 Psilocybin and the Development of Serotonin Toxicity.The primary care companion for CNS disorders · 2024-02-29